SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-005259
Filing Date
2024-09-19
Accepted
2024-09-19 06:05:08
Documents
2
Period of Report
2024-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_091924.htm 6-K 6471
2 PRESS RELEASE exh_991.htm EX-99.1 7161
  Complete submission text file 0001171843-24-005259.txt   14652
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39179 | Film No.: 241308755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)